Skip to Main Content

Advertisement

Skip Nav Destination

Abstract LB-384: Elevated eIF4E phosphorylation is associated with advanced malignancy and decreased patient survival and can be therapeutically inhibited by a novel, orally bio-available Mnk inhibitor

Cancer Res (2011) 71 (8_Supplement): LB-384.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal